Transdermal Patches: Global Markets
Description
Transdermal Patches: Global Markets
Report Scope:
This report aims to provide a comprehensive study of the global market for transdermal patches. It provides a detailed description of the different types of transdermal patch products and technology, as well as their current and historical market revenues.
Transdermal patches can be separated by their differing designs and technology, along with their applications. Transdermal patch technologies include matrix, reservoir, and other transdermal drug delivery technologies/systems.
This report also covers a detailed study of therapeutic applications of transdermal drug delivery, including pain, central nervous system disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders, and others. This in-depth analysis of the global market for transdermal patches includes historical data and market projections for sales segment by technology/system type, product, application, design, and region.
For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technologies/devices market.
Report Includes:
122 data tables and 53 additional tables
An overview of the global transdermal patches market
Estimation of the market size and analyses of global market trends, with data from 2019-2022, with projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current and future market potential and quantification of transdermal patches market based on type, design, technology, application, and region
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
Analysis of transdermal patches pipeline products with focus on promising pipeline molecules/ drugs in development, and coverage of technological advances, scientific discoveries, and new therapies
Detailed analysis of the regulatory framework and policies, and snapshot of transdermal drug delivery system
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Comprehensive company profiles of the leading players of the industry, including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd.
Companies Mentioned
ABBVIE INC.
ALVOGEN
Amneal Pharmaceuticals, Inc.
Bausch Health Companies Inc.
BAYER HEALTHCARE PHARMACEUTICALS
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
GRÜNENTHAL GMBH
HISAMITSU PHARMACEUTICAL CO., INC.
ICURE PHARMA INC.
JOHNSON & JOHNSON
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
Perrigo Company plc
PURDUE PHARMA L.P.
SPARSHA PHARMA INTERNATIONAL PVT. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.
Report Scope:
This report aims to provide a comprehensive study of the global market for transdermal patches. It provides a detailed description of the different types of transdermal patch products and technology, as well as their current and historical market revenues.
Transdermal patches can be separated by their differing designs and technology, along with their applications. Transdermal patch technologies include matrix, reservoir, and other transdermal drug delivery technologies/systems.
This report also covers a detailed study of therapeutic applications of transdermal drug delivery, including pain, central nervous system disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders, and others. This in-depth analysis of the global market for transdermal patches includes historical data and market projections for sales segment by technology/system type, product, application, design, and region.
For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technologies/devices market.
Report Includes:
122 data tables and 53 additional tables
An overview of the global transdermal patches market
Estimation of the market size and analyses of global market trends, with data from 2019-2022, with projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current and future market potential and quantification of transdermal patches market based on type, design, technology, application, and region
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
Analysis of transdermal patches pipeline products with focus on promising pipeline molecules/ drugs in development, and coverage of technological advances, scientific discoveries, and new therapies
Detailed analysis of the regulatory framework and policies, and snapshot of transdermal drug delivery system
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Comprehensive company profiles of the leading players of the industry, including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd.
Companies Mentioned
ABBVIE INC.
ALVOGEN
Amneal Pharmaceuticals, Inc.
Bausch Health Companies Inc.
BAYER HEALTHCARE PHARMACEUTICALS
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
GRÜNENTHAL GMBH
HISAMITSU PHARMACEUTICAL CO., INC.
ICURE PHARMA INC.
JOHNSON & JOHNSON
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
Perrigo Company plc
PURDUE PHARMA L.P.
SPARSHA PHARMA INTERNATIONAL PVT. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.
Table of Contents
262 Pages
- Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing This Study
- 1.3 Scope of Report
- 1.4 Information Sources
- 1.5 Methodology
- 1.6 Geographic Breakdown
- 1.7 Analyst's Credentials
- 1.8 BCC Custom Research
- 1.9 Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Market Overview
- 3.1 Overview of Transdermal Drug Delivery Systems
- 3.2 Mechanism of Transdermal Drug Delivery
- 3.3 Advantages of Transdermal Drug Delivery
- 3.4 Disadvantages of Transdermal Drug Delivery
- 3.5 Types of Transdermal Drug Delivery Systems Based on System Types/Forms
- 3.5.1 Transdermal Patch
- 3.6 Types of Transdermal Drug Delivery Systems Based on Technology Types
- 3.6.1 Types of Passive Transdermal Drug Delivery Systems
- 3.6.2 Active Transdermal Drug Delivery Systems
- 3.6.3 Types of Active Transdermal Drug Delivery System
- 3.4 Overview of Clinical Application Areas of Transdermal Drug Delivery Technologies/Systems
- 3.4.1 Pain Management
- 3.4.2 Central Nervous System Disorders
- 3.4.3 Hormonal Applications
- 3.4.4 Smoking Cessation
- 3.4.5 Motion Sickness
- 3.4.6 Cardiovascular Diseases
- 3.4.7 Others
- 3.5 Pain Management Patches
- 3.5.1 Prevalence of Chronic Pain
- 3.5.2 Trends in Pain Management Patches
- Chapter 4 Market Dynamics
- 4.1 Market Dynamics
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- Chapter 5 Impact of COVID-19 on Pharma Industry
- 5.1 Overview
- 5.2 Short-term Impact on the Pharma Industry
- 5.3 Long-term Impact on the Pharma Industry
- 5.4 COVID-19 and Pain Management
- 5.4.1 Telemedicine
- Chapter 6 Emerging Technology in Transdermal Patches
- 6.1 Emerging Technology
- 6.1.1 Transdermal Patches and Orally Dissolving Film (ODF)
- 6.1.2 Nemaura Pharma Transdermal Technology
- Chapter 7 Global Market for Transdermal Patches by Product Type
- 7.1 Introduction
- 7.2 Hormonal Patches
- 7.3 Neuro Drug Patches
- 7.4 Nicotine Patches
- 7.5 Cardiac and Blood-related Patches
- 7.6 Pain Relief Patches
- 7.6.1 Market Outlook
- 7.7 Other Patches
- Chapter 8 Global Market for Transdermal Patches by Design
- 8.1 Overview
- 8.2 Microderm
- 8.3 Macroperm
- 8.4 IontoPatch
- Chapter 9 Global Market for Transdermal Patches by Technology
- 9.1 Global Market for Transdermal Patches by Technology
- Chapter 10 Global Market for Transdermal Patches by Application
- 10.1 Global Market for Transdermal Patches by Application
- 10.2 Chronic Pain
- 10.3 Acute Pain
- 10.4 Neural Diseases
- 10.5 Hormonal Applications
- 10.6 Smoking Cessation
- 10.7 Cardiac and Blood Diseases
- 10.8 Other Applications
- Chapter 11 Global Market for Transdermal Patches by Region
- 11.1 Global Markets for Transdermal Patches by Region
- 11.2 North America
- 11.2.1 United States
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 Italy
- 11.3.3 France
- 11.3.4 United Kingdom
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia-Pacific
- 11.4.1 Japan
- 11.4.2 India
- 11.4.3 Australia
- 11.4.4 China
- 11.4.5 Rest of Asia-Pacific
- 11.5 Rest of the World
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 GCC Countries
- 11.5.4 Rest of the World Countries
- Chapter 12 Competitive Landscape
- 12.1 Global Analysis of Company Shares
- Chapter 13 Company Profiles
- ABBVIE INC.
- ALVOGEN
- AMNEAL PHARMACEUTICALS, INC.
- BAUSCH HEALTH COMPANIES INC.
- BAYER HEALTHCARE PHARMACEUTICALS
- ENDO PHARMACEUTICALS INC.
- GLAXOSMITHKLINE PLC
- GRUNENTHAL GMBH
- HISAMITSU PHARMACEUTICAL CO., INC.
- ICURE PHARMA INC.
- JOHNSON & JOHNSON
- LAVIPHARM S. A.
- LUYE PHARMA GROUP LTD.
- NOVARTIS AG
- PERRIGO COMPANY PLC
- PURDUE PHARMA L.P.
- SPARSHA PHARMA INTERNATIONAL PVT. LTD.
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- VIATRIS INC.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
